Publication | Open Access
Synergistic therapeutic combination with a CAF inhibitor enhances CAR-NK-mediated cytotoxicity via reduction of CAF-released IL-6
52
Citations
31
References
2023
Year
Our strategy against PDGFRβ<sup>+</sup>-CAF-containing pancreatic cancer allows improvements in the therapy of pancreatic ductal adenocarcinoma.
| Year | Citations | |
|---|---|---|
Page 1
Page 1